Clinical Trial Search

Primary: Percentage of Participants With Clinically Evident Verified Post-Operative Cerebrospinal Fluid Leak or Clinically Evident Pseudomeningocele or Treatment Failure — 6.9…

Primary: Maximum Papillae — 1.50; 1.00; 1.50; 1.00 Units on a scale

Primary: Percent Change in Inflammatory Acne Lesion Counts — -28.6; -44.3; -44.4 Percentage change from baseline — p=0.1919

Primary: Presence of Unequivocal Beginning of Relief of the Defining Attack Symptom — 3; 3; 3; 0 participants

Primary: Self-Report of Adequate Relief of Dyspepsia (Yes/No) For at Least 50% of Weeks 3 -12 of Treatment — 53; 38; 40 percentage of participants — p=0.05

Primary: Incidence of Prolonged Hematologic Toxicity Started in Cycle 1 — 0; 0 Percentage of Participants

Primary: Number of Participants With Overall Response — 25; 27 participants

Primary: Change From Baseline to 6 Months Post-enrollment in RAND 36-Item Health Survey 'Physical Functioning' Scale Scores — 49.3; 56.2 scores on a scale — p=0.03

Primary: Time — 144.2; 145.3; 145.3; 144.8 seconds

Primary: Number of Participants With Adverse Events (AEs) — 15 participants

Primary: Changes in Hemodynamic Parameters of Radial/Ulnar Artery From Baseline to 30min After Specific Nerve Block Followed by 30min After Brachial Plexus Block(Phase 1) — 40.9…

Primary: TcCo2 vs PACo2 Difference — 3.2 mmHG

Primary: The Association of HVPG and PUD in Patients With Liver Cirrhosis — 14.5; 15.3 mmHg

Primary: Depression Score — 13; 52 percentage of participants

Primary: Change From Baseline in C-terminal Propeptide of Procollagen Type I (PICP) — -5.22; -4.25 ug/l